Neuropsicofarmacología molecular
Universitat Autònoma de Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Universitat Autònoma de Barcelona (9)
2022
-
The role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal study
European Neuropsychopharmacology, Vol. 57, pp. 105-117
2021
-
Analysis of molecular networks in the cerebellum in chronic schizophrenia: Modulation by early postnatal life stressors in murine models
International Journal of Molecular Sciences, Vol. 22, Núm. 18
-
Gut microbiota, innate immune pathways, and inflammatory control mechanisms in patients with major depressive disorder
Translational Psychiatry, Vol. 11, Núm. 1
-
Kynurenine pathway in post-mortem prefrontal cortex and cerebellum in schizophrenia: relationship with monoamines and symptomatology
Journal of Neuroinflammation, Vol. 18, Núm. 1
2019
-
Association of chronic inflammation and perceived stress with abnormal functional connectivity in brain areas involved with interoception in hepatitis C patients
Brain, Behavior, and Immunity, Vol. 80, pp. 204-218
-
CIBERSAM: Ten years of collaborative translational research in mental disorders
Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 1, pp. 1-8
2017
-
Differential regulation of the TLR4 signalling pathway in post-mortem prefrontal cortex and cerebellum in chronic schizophrenia: Relationship with SP transcription factors
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 79, pp. 481-492
2014
-
Early responses to deep brain stimulation in depression are modulated by anti-inflammatory drugs
Molecular Psychiatry, Vol. 19, Núm. 5, pp. 607-614
2012
-
JNK/ERK/FAK Mediate promigratory actions of basic fibroblast growth factor in astrocytes via CCL2 and COX2
NeuroSignals, Vol. 20, Núm. 2, pp. 86-102